«Kidney Glomerulus

Below is an extended Kidney Glomerulus patents listing. Click here to return to the Kidney Glomerulus main in depth entry.

Patents :
US Patent No.	Title
6342221	Antibody conjugate compositions for selectively inhibiting VEGF
6562371	Liposomes
6610693	Fructosamine oxidase: antagonists and inhibitors
6610839	Promoter for telomerase reverse transcriptase
6617110	Cells immortalized with telomerase reverse transcriptase for use in drug screening
6676941	Antibody conjugate formulations for selectively inhibiting VEGF
6683056	O-aryl glucoside SGLT2 inhibitors and method
6703020	Antibody conjugate methods for selectively inhibiting VEGF
6774112	Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
6780850	Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
6783734	Convex geometry adhesive film system for laser capture microdissection
6555519	O-glucosylated benzamide SGLT2 inhibitors and method
6524583	Antibody methods for selectively inhibiting VEGF
6515117	C-aryl glucoside SGLT2 inhibitors and method
6348465	Fructosamine oxidase: antagonists and inhibitors
6359126	Antibodies to .alpha.v.beta.3 integrin
6369204	Antibodies to .alpha.v.beta.3 integrin
6414126	C-aryl glucoside SGLT2 inhibitors and method
6416758	Antibody conjugate kits for selectively inhibiting VEGF
6436669	Semaphorin genes (I)
6475789	Human telomerase catalytic subunit: diagnostic and therapeutic methods
6479072	Microfabricated membranes and matrices
6492325	Use of .alpha.1.beta.1 integrin receptor inhibitors and TGF-.beta.1 inhibitors in the treatment of kidney disease
6500627	Methods for predicting pregnancy outcome in a subject by HCG assay
6803438	Uniform molecular weight polymers
6825395	Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)
7198954	Methods for predicting pregnancy outcome in a subject by hCG assay
7199234	Regulatory segments of the human gene for telomerase reverse transcriptase
7214375	Methods of decreasing the accumulation of extracellular matrix associated with glomerulonephritis with anti-TGF-.beta.-specific antibodies
7262288	Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7285391	Methods for predicting pregnancy outcome in a subject by hCG assay
7291451	Modulation of pericyte proliferation
7351541	Method for diagnosing a renal disorder
7375213	Methods of producing C-aryl glucoside SGLT2 inhibitors
7399636	Diagnostic kit for predicting pregnancy outcome
7413864	Treating cancer using a telomerase vaccine
7195911	Mammalian cells that have increased proliferative capacity
7135336	Use of Xenopus laevis oocytes a microincubators
7112412	Treatment and diagnosis of prostate cancer
6828412	Degradable polymers
6861254	Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor
6887468	Antibody kits for selectively inhibiting VEGF
6897243	Fructosamine oxidase: antagonists and inhibitors
6927034	Methods for detecting trophoblast malignancy by HCG assay
6936590	C-aryl glucoside SGLT2 inhibitors and method
6984720	Human CTLA-4 antibodies
7056509	Antibody methods for selectively inhibiting VEGF
7105291	Nephrin gene and protein
7109000	Proteins and nucleic acids encoding same
7416885	Proliferated cell lines and uses thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.